(Q62025528)
Statements
A Phase I, Open-label, Single-center Relative Bioavailability and Food Effect Randomized Crossover Study of New Granule and Capsule Formulations of Selumetinib (AZD6244) in Healthy Male Subjects (English)
0 references
5 September 2018
0 references
21 October 2018
0 references
24
0 references
18 year
0 references
45 year
0 references